Feb 2022 $24 M No. 6 $10 to $50 million 54
Vascular Therapies LLC: Raise no. 6, Feb 2022 × Investors in this round 54 investors had bought by the notice of Mar 4, 2022: 54 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $25 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John McDermott · Executive Officer, Director Sriram Iyer · Executive Officer, Director Allan Tessler · Director Andrew Midler · Director Daniel Ryan · Director Gerald Dorros · Director Robert Croce · Director Robert Flanagan · Director Somu Subramaniam · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John McDermott, Chief Executive Officer. Newest notice filed Mar 4, 2022. Read the notice at the SEC .
equity SEC Oct 2018 $12 M No. 5 $10 to $50 million 29
Vascular Therapies LLC: Raise no. 5, Oct 2018 × Investors in this round 29 investors had bought by the notice of Oct 12, 2018: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $21 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Sriram Iyer · Executive Officer, Director Allan Tessler · Director Andrew Midler · Director Dan Ryan · Director Gerald Dorros · Director Kiyoshi Takesue · Director Robert Croce · Director Robert Flanagan · Director Somu Subramaniam · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Sriram Iyer, President. Newest notice filed Oct 12, 2018. Read the notice at the SEC .
equity SEC Feb 2015 $31 M No. 4 $10 to $50 million 33
Vascular Therapies LLC: Raise no. 4, Feb 2015 × Investors in this round 33 investors had bought by the notice of Dec 30, 2016: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $31 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Sriram Iyer · Executive Officer, Director Allan Tessler · Director Gerald Dorros · Director Kiyoshi Takesue · Director Michael Bamberger · Director Robert Croce · Director Robert Flanagan · Director Somu Subramaniam · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Sriram Iyer, Chairman and President. Newest notice filed Dec 30, 2016 (1 amendment). Read the notice at the SEC .
equity SEC Jun 2012 $5 M No. 3 $2 to $10 million 11
Vascular Therapies LLC: Raise no. 3, Jun 2012 × Investors in this round 11 investors had bought by the notice of Jul 12, 2013: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $15 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $750,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Sriram Iyer · Executive Officer, Director Allan Tessler · Director Gerald Dorros · Director Kiyoshi Takesue · Director Michael Bamberger · Director Robert Croce · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ROBERTS MITANI, LLC (CRD 30022) · New York, New York Sold in FL, NY Signed by Sriram Iyer, M.D., Chairman and President. Newest notice filed Jul 12, 2013 (1 amendment). Read the notice at the SEC .
equity SEC May 2011 $3 M No. 2 $2 to $10 million 30
Vascular Therapies LLC: Raise no. 2, May 2011 × Investors in this round 30 investors had bought by the notice of Jun 14, 2011: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Paul M. Barkofsky · Executive Officer Sriram M. Iyer · Executive Officer, Director Gerald M. Dorros · Director Michael M. Bamberger · Director Robert M. Croce · Director Samuel M. Liang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Sriram Iyer, Executive Officer. Newest notice filed Jun 14, 2011. Read the notice at the SEC .
equity SEC Feb 2009 $1 M No. 1 Under $2 million 22
Vascular Therapies LLC: Raise no. 1, Feb 2009 × Investors in this round 22 investors had bought by the notice of Apr 25, 2011: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Sriram M. Iyer · Executive Officer, Director Gerald M. Dorros · Director Michael M. Bamberger · Director Paul M. Barkofsky · Director Robert M. Croce · Director Samuel M. Liang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Sriram Iyer, Executive Officer. Newest notice filed Apr 25, 2011. Read the notice at the SEC .
debt, options SEC